Portal de Periódicos da CAPES

Near-Infrared Fluorescence Imaging in Patients Undergoing Pancreaticoduodenectomy

2011; Karger Publishers; Volume: 47; Issue: 2 Linguagem: Inglês

10.1159/000329411

1421-9921

Merlijn Hutteman, Joost R. van der Vorst, J. Sven D. Mieog, Bert A. Bonsing, H.H. Hartgrink, Peter J.K. Kuppen, Clemens W.G.M. Löwik, John V. Frangioni, Cornelis J.�H. van de Velde, Alexander L. Vahrmeijer,

Renal cell carcinoma treatment

<i>Background:</i> Intraoperative visualization of pancreatic tumors has the potential to improve radical resection rates. Intraoperative visualization of the common bile duct and bile duct anastomoses could be of added value. In this study, we explored the use of indocyanine green (ICG) for these applications and attempted to optimize injection timing and dose. <i>Methods:</i> Eight patients undergoing a pancreaticoduodenectomy were injected intravenously with 5 or 10 mg ICG. During and after injection, the pancreas, tumor, common bile duct and surrounding organs were imaged in real time using the Mini-FLARE™ near-infrared (NIR) imaging system. <i>Results:</i> No clear tumor-to-pancreas contrast was observed, except for incidental contrast in 1 patient. The common bile duct was clearly visualized using NIR fluorescence, within 10 min after injection, with a maximal contrast between 30 and 90 min after injection. Patency of biliary anastomoses could be visualized due to biliary excretion of ICG. <i>Conclusion:</i> No useful tumor demarcation could be visualized in pancreatic cancer patients after intravenous injection of ICG. However, the common bile duct and biliary anastomoses were clearly visualized during the observation period. Therefore, these imaging strategies could be beneficial during biliary surgery in cases where the surgical anatomy is aberrant or difficult to identify.